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Late onset of isovaleric acidemia presenting 
with bicytopenia
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To the Editor,
Isovaleric academia (IVA) is an autosomal reces-
sive inborn error of leucine metabolism caused by 
a deficiency of isovaleryl-CoA dehydrogenase. In 
the acute phase of this disease, thrombocytopenia, 
neutropenia or pancytopenia may be common fea-
tures [1-4]. However, the physiopathology of the 
bone marrow suppression in this disease is still 
unclear. Here, we report the case of an IVA patient 
who presented with thrombocytopenia and neutro-
penia at the age of 31 months.
A 31-month-old male patient had been admitted 
to our hospital with fever, vomiting, fatigue, and loss 
of appetite. There was no history of any drug use. 
On physical examination, the patient was lethargic. 
Vital signs were normal except for mild tachycardia 
and tachypnea. Skin turgor and tonus were found to 
be decreased. 
The results of a complete blood count revealed 
the following: white blood cells (WBC) count 
1.4x109/L; absolute neutrophil count 0.92x109/L; 
hemoglobin 11 g/dl; and platelet count 57.5x109/L. 
The bone marrow aspiration showed normal matu-
ration of three lineages without any hemophagocy-
tosis, megaloblastic cells, extramyeloid cells, fatty 
changes, or myelodysplasia. There were numerous 
necrotic cells. The number and the morphology of 
megakaryocytes were normal. In the aspiration 
smear, 18% myelocyte, 35% metamyelocyte, 11% 
polymorphonuclear leukocyte, 28% lymphocyte, 2% 
normoblast, 1% monocyte, 1% eosinophil, and 4% 
lymphoblast-like cells were present. Bone marrow 
flow cytometry did not reveal lymphoblasts. 
Biochemical analyses were within normal limits 
except for hypocalcemia, hyperammonemia, and 
mildly increased aspartate aminotransferase and 
lactate dehydrogenase. Serum C-reactive protein 
and erythrocyte sedimentation rate were in normal 
range. Ketonuria was determined. The results of 
blood, throat, urine, stool, and cerebrospinal fluid 
cultures were negative. Viral serology of the cere-
brospinal fluid and serum were also negative. 
Serum Brucella agglutination and Salmonella agglu-
tination were negative. Serum lactate and pyruvate 
levels were 4 mmol/L (normal range: 0.7-2.1 
mmol/L), and 2.74 mg/dl (normal range: 0.3-1 mg/
dl), respectively. The urine organic acid examina-
tion showed that the excretions of isovaleryl glycine 
and methyl malonic acid were significantly increased: 1299 mmol/mol creatinine (normal: 0 
mmol/mol creatinine) and 42.7 mmol/mol creati-
nine (normal: 0 mmol/mol creatinine), respectively. 
Tandem mass spectrometry of spot serum, free car-
nitine and amino acid profiles were normal. There 
was an increase in the isovaleryl and 3-OH butyryl 
carnitine levels, whereas there was a decrease in 
the levels of acetyl, propionyl, and palmitoylcarni-
tine. Lymphocyte isovaleryl-CoA dehydrogenase 
activity was 0.02 nmol/min.mg [controls mean±SD: 
1.51±0.31 nmol/min.mg].
We initiated antibiotic therapy and protein-poor 
diet. Carnitine and L-glycine were added to the treat-
ment. During this period, his laboratory examination 
revealed WBC count of 0.64x109/L (absolute neutro-
phil count, 0.43x109/L); a hemoglobin level of 10.7 g/
dl; and a platelet count of 31.8x109/L. On the fifth day 
of antibiotics, his fever was controlled, and the WBC 
number and platelet count began to increase. His 
blood count was completely normal one week after 
the end of antibiotic treatment (Figure 1a, b).
Hematologic problems can be seen in patients 
with inborn errors of branched-chain amino acid 
metabolism. Various cytopenias have been reported 
in IVA [5]. However, the physiopathology of myelo-
suppression in this disease is not well known. Some 
infections may also result in myelosuppression, but 
in our patient, we did not determine any serologic 
or microbiologic evidence of infection. There is also 
a report of a patient with IVA with promyelocytic 
myeloproliferative syndrome [6,7]. In patients with 
IVA, hematologic problems are usually reported in 
early infancy [1,2,6]. Compatible with this, no 
patients have been reported in the English literature 
with IVA diagnosed later in childhood with neutro-
penia, thrombocytopenia or pancytopenia. 
In some patients, this disorder may be diagnosed 
as late as 5 years [8]. However, hematologic prob-
lems are not observed at that age. Another interest-
ing finding in our patient was the lymphoblast-like 
cells observed in the bone marrow. We believe that 
the lymphoblast-like cells observed in our patient’s 
bone marrow were due to maturation arrest in the 
normal lymphoblastic series caused by IVA. 
Although both forms of IVA often occur in the first 
year of life, IVA may be observed later in childhood. 
Hematologic problems frequently observed in the acute 
form of the disease can be seen in the chronic intermit-
tent form, as was the case in our patient. Thus, in such 
cytopenias, inborn errors of branched -chain amino acid 
metabolism, like IVA, should be kept in mind. 
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